Cardiac Amyloidosis Clinical Trial
— PAPCATOfficial title:
Prevalence and Prognosis of Cardiac Amiloidosis in Turkey- Registry Study
Patients with left ventricular hypertrophy are further examined according to an algorithm to check if they have a cardiac amyloidosis
| Status | Recruiting |
| Enrollment | 2087 |
| Est. completion date | December 31, 2025 |
| Est. primary completion date | December 31, 2025 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Patients with left ventricular hypertrophy without left ventricular pressure or volume (IVS=13mm) - Patients with left ventricular hypertrophy and hypertension or aortic stenosis without left ventricular pressure or volume (IVS>15mm) Exclusion Criteria: - Patients with left ventricular pressure or volume except the ones with aortic stenosis and arterial hypertension - Patients with sigmoid septum and their hypertrophy limited in sigmoid area - Patients with highly probable sarcometric hypertrophy cardiomyopathy confirmed with LV morhpology and genetic testing |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Dokuz Eylul University Faculty of Medicine | Izmir |
| Lead Sponsor | Collaborator |
|---|---|
| Turkish Society of Cardiology |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Cardiac Amyloidosis | Patients with left ventricular hypertrophy and Cardiac Amyloidosis | Upon screening |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04459169 -
Cardiac Amyloidosis : Diagnostic Using Red Flag Signals
|
||
| Recruiting |
NCT03029026 -
The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
|
||
| Recruiting |
NCT06034405 -
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
|
||
| Recruiting |
NCT02966522 -
Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis
|
Phase 2 | |
| Terminated |
NCT03333551 -
Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy
|
Phase 4 | |
| Recruiting |
NCT04105634 -
Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT
|
Early Phase 1 | |
| Recruiting |
NCT05139797 -
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
|
||
| Not yet recruiting |
NCT05593679 -
A Multi-center Cardiac PYP Scan Registry in Taiwan.
|
||
| Not yet recruiting |
NCT04146415 -
Diagnosis of Cardiac Amyloidosis With 99mTc-PYP; Comparison Between Planar Imaging, SPECT/CT and Cardiac-dedicated CZT Camera
|
N/A | |
| Not yet recruiting |
NCT06427304 -
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
|
||
| Recruiting |
NCT06469372 -
Cardiac Amyloidosis Discovery Trial
|
N/A | |
| Recruiting |
NCT04856267 -
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
|
||
| Completed |
NCT03119558 -
PET/MRI Evaluation of Cardiac Amyloid
|
Early Phase 1 | |
| Recruiting |
NCT02798705 -
Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis
|
||
| Not yet recruiting |
NCT04387344 -
Morpho-functional Cardiac Modifications in Treated Mutated Transthyretin Cardiac Amyloidosis
|
||
| Recruiting |
NCT06129656 -
Cardiac Amyloidosis Registry of University Hospital Leipzig
|
||
| Terminated |
NCT01683825 -
Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography
|
Phase 4 | |
| Withdrawn |
NCT04363294 -
Targeted Testing for ATTR Among Aortic Stenosis Patients-Pilot
|
N/A | |
| Not yet recruiting |
NCT04661800 -
Study of Olfactory Disorders in Patients With Cardiac Amyloidosis
|
N/A | |
| Terminated |
NCT03232632 -
Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries.
|
Early Phase 1 |